Frontlight ResearchEarly access
CompletedNo phase
Serotype Distribution in Hospitalized Adult With Pneumococcal Community Acquired Pneumonia in France
Key facts
- Who runs it
- Institut National de la Santé Et de la Recherche Médicale, France
- Where
- France5 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 1,017 people enrolled
- Started
- 9 May 2022
- Ended
- 6 Feb 2025
- Type of study
- Observational
- Record updated
- 15 May 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Adults 18 years of age or older
- Admission to hospital for at least 24 hours
- Suspicion of community-acquired pneumonia at admission defined as the association of: Radiologic findings consistent with pneumonia (eg, pleural effusion, increased pulmonary density due to infection and/or alveolar infiltrates [multilobar, lobar, or segmental] containing air bronchograms), AND The presence of ≥2 of the following signs or symptoms: Fever (oral temperature >38°C or tympanic temperature >38.5°C) in the 24 hours preceding admission; Hypothermia (<35.5°C measured by a healthcare provider) in the 24 hours preceding admission ; Chills or rigors ; Pleuritic chest pain ; New or worsening cough ; Sputum production ; Dyspnea (shortness of breath); Tachypnea (respiratory rate >20/min) ; Malaise ; Abnormal auscultatory findings suggestive of pneumonia (rales or evidence of pulmonary consolidation)
- Written informed consent from the patient
Who cannot take part
- Suspicion of tuberculosis
- Individuals placed under judicial protection
- Individuals who refuse the transfer of biological samples to the USA
- Patient developing signs and symptoms of pneumonia after having been hospitalized for 48 hours or more
- Pregnancy
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
CAP'Hospi is an observational, multicentric study in France which primary objective is to describe the proportion of Community Acquired Pneumonia due to serotypes included in PCV20 among adults hospitalized for CAP
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 15 May 2025